10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001104659-23-055992`
Period End Date	20230331
Filing Date	20230504
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	cldx-20230331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 30 Cash Flow Statement 44

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.43M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$224.26M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$275.52M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.31M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$347.00K	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.39M	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.90M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$317.69M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	47.24M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$289.60M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	47.20M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	47.24M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	47.20M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.75M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$4.00M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.63M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$27.19M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$27.19M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$104.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$104.00K	USD	Point-in-time
Total assets	`Assets`	$324.52M	USD	Point-in-time
Total assets	`Assets`	$352.74M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.37M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.34M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.84M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.37M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.49M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.45M	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$978.00K	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$990.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.61M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.22M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.16M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.59M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.33M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.40M	USD	Point-in-time
Total liabilities	`Liabilities`	$21.78M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.53M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at March 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 47,244,681 and 47,200,695 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 47,244,681 and 47,200,695 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.59B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.58B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.26M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.26B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.29B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$326.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$398.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$302.74M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$419.48M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$352.74M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$324.52M	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$174.00K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$967.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$17.06M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$26.80M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.64M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.91M	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$536.00K	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$23.43M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$33.44M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-32.47M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-23.26M	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$207.00K	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$3.11M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasic`	$-0.49	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasic`	$-0.62	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareDiluted`	$-0.49	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareDiluted`	$-0.62	USD	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	47,214.00	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	46,739.00	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	47,214.00	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	46,739.00	shares	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.78M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$863.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-28.50M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-24.83M	USD	1 Quarter

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$726.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$811.00K	USD	1 Quarter
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-772.00K	USD	1 Quarter
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.26M	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$536.00K	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.15M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$4.34M	USD	1 Quarter
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$71.00K	USD	1 Quarter
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$967.00K	USD	1 Quarter
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.72M	USD	1 Quarter
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.15M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.74M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-3.45M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.32M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$4.27M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-24.53M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-28.57M	USD	1 Quarter
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$127.00M	USD	1 Quarter
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$27.84M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$73.85M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$16.89M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$585.00K	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$575.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$10.38M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$52.57M	USD	1 Quarter
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$304.00K	USD	1 Quarter
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$694.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$304.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$694.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$24.69M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-13.85M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.43M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$54.12M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.29M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.43M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$54.12M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.29M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.14M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$53.00K	USD	1 Quarter
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$134.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.